MTHFR and chronic kidney disease: In agreement with the findings of the study by Lee et al. [27], we detected no significant difference in the homocysteine level among the 3 MTHFR genotypes in patients with end-stage renal disease, which is considered to be relevant in the pathogenesis of MTHFR-related thrombotic events [30].